Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1996 May;88(1):124–129. doi: 10.1046/j.1365-2567.1996.d01-633.x

Impact of donor MHC class I or class II antigen deficiency on first- and second-set rejection of mouse heart or liver allografts.

S Qian 1, F Fu 1, Y Li 1, L Lu 1, A S Rao 1, T E Starzl 1, A W Thomson 1, J J Fung 1
PMCID: PMC1456472  PMID: 8707337

Abstract

The influence of donor major histocompatibility complex (MHC) class I- or class II-deficiency on the initiation of first- and second-set rejection of mouse heart and liver allografts was examined. C3H (H-2k) mice received heterotopic cardiac or orthotopic liver grafts from unmodified B10 (H-2b), B6 (H-2b), b2m (H-2b; class I deficient) or AB0 (H-2b; class II deficient) donors. Organ survival was also investigated in C3H recipients that had been presensitized by a normal B10 skin graft 2-3 weeks before heart or liver transplantation. The absence of cell surface MHC class I or class II resulted in significant prolongation of primary cardiac allograft survival. Three of seven (43%) MHC class I-deficient, and two of five (40%) class II-deficient heart grafts were accepted indefinitely (survival time > 100 days). Thus both MHC class I and class II molecules appear to be important for the elicitation of first-set rejection in the heart allograft model. All liver allografts survived > 100 days in normal recipients. In C3H recipients that had been presensitized by a B10 skin graft, however, both heart and liver grafts from AB0 (class II deficient) donors underwent accelerated rejection (median survival time [MST] 3 and 4 days, respectively). In contrast, liver grafts from class I-deficient mice (b2m) were still accepted indefinitely by B10 skin-presensitized C3H recipients, whereas class I-deficient hearts survived significantly longer than those from class II-deficient or normal donors. These data demonstrate that the expression of donor MHC class I, and not class II is crucial in initiating second-set organ allograft rejection. In vitro monitoring revealed that at the time of organ transplant, both splenocytes and serum of the skin-presensitized animals displayed high cytotoxicity against AB0 (class II-deficient) but not against b2m (class I-deficient) targets.

Full text

PDF
124

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Auchincloss H., Jr, Lee R., Shea S., Markowitz J. S., Grusby M. J., Glimcher L. H. The role of "indirect" recognition in initiating rejection of skin grafts from major histocompatibility complex class II-deficient mice. Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3373–3377. doi: 10.1073/pnas.90.8.3373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BILLINGHAM R. E., BRENT L., MEDAWAR P. B. Actively acquired tolerance of foreign cells. Nature. 1953 Oct 3;172(4379):603–606. doi: 10.1038/172603a0. [DOI] [PubMed] [Google Scholar]
  3. Berzofsky J. A., Brett S. J., Streicher H. Z., Takahashi H. Antigen processing for presentation to T lymphocytes: function, mechanisms, and implications for the T-cell repertoire. Immunol Rev. 1988 Dec;106:5–31. doi: 10.1111/j.1600-065x.1988.tb00771.x. [DOI] [PubMed] [Google Scholar]
  4. Buelow R., Burlingham W. J., Clayberger C. Immunomodulation by soluble HLA class I. Transplantation. 1995 Mar 15;59(5):649–654. doi: 10.1097/00007890-199503150-00001. [DOI] [PubMed] [Google Scholar]
  5. Carpenter C. B., Morris P. J. The detection and measurement of pretransplant sensitization. Transplant Proc. 1978 Jun;10(2):509–513. [PubMed] [Google Scholar]
  6. Christiaans M., Van den Berg-Loonen E., Ten Haaft A., Nieman F., Van Hooff J. Effect of flow cytometry, complement-dependent cytotoxicity, and auto cross match on cadaveric renal transplant outcome. Transplant Proc. 1995 Feb;27(1):1028–1030. [PubMed] [Google Scholar]
  7. Dahmen U., Qian S., Rao A. S., Demetris A. J., Fu F., Sun H., Gao L., Fung J. J., Starzl T. E. Split tolerance induced by orthotopic liver transplantation in mice. Transplantation. 1994 Jul 15;58(1):1–8. doi: 10.1097/00007890-199407000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Feucht H. E., Schneeberger H., Hillebrand G., Burkhardt K., Weiss M., Riethmüller G., Land W., Albert E. Capillary deposition of C4d complement fragment and early renal graft loss. Kidney Int. 1993 Jun;43(6):1333–1338. doi: 10.1038/ki.1993.187. [DOI] [PubMed] [Google Scholar]
  9. Goulmy E., Persijn G., Blokland E., D'Amaro J., van Rood J. J. Cell-mediated lympholysis studies in renal allograft recipients. Transplantation. 1981 Mar;31(3):210–217. doi: 10.1097/00007890-198103000-00014. [DOI] [PubMed] [Google Scholar]
  10. Grusby M. J., Johnson R. S., Papaioannou V. E., Glimcher L. H. Depletion of CD4+ T cells in major histocompatibility complex class II-deficient mice. Science. 1991 Sep 20;253(5026):1417–1420. doi: 10.1126/science.1910207. [DOI] [PubMed] [Google Scholar]
  11. Halloran P. F., Schlaut J., Solez K., Srinivasa N. S. The significance of the anti-class I response. II. Clinical and pathologic features of renal transplants with anti-class I-like antibody. Transplantation. 1992 Mar;53(3):550–555. [PubMed] [Google Scholar]
  12. Herbert J., Roser B. Lymphocyte subpopulations and memory of MHC antigens. I. Quantitative aspects of neonatal heart graft rejection in normal and immune rats. Transplantation. 1987 Apr;43(4):556–560. doi: 10.1097/00007890-198704000-00020. [DOI] [PubMed] [Google Scholar]
  13. Koller B. H., Marrack P., Kappler J. W., Smithies O. Normal development of mice deficient in beta 2M, MHC class I proteins, and CD8+ T cells. Science. 1990 Jun 8;248(4960):1227–1230. doi: 10.1126/science.2112266. [DOI] [PubMed] [Google Scholar]
  14. Lechler R. I., Lombardi G., Batchelor J. R., Reinsmoen N., Bach F. H. The molecular basis of alloreactivity. Immunol Today. 1990 Mar;11(3):83–88. doi: 10.1016/0167-5699(90)90033-6. [DOI] [PubMed] [Google Scholar]
  15. Markmann J. F., Bassiri H., Desai N. M., Odorico J. S., Kim J. I., Koller B. H., Smithies O., Barker C. F. Indefinite survival of MHC class I-deficient murine pancreatic islet allografts. Transplantation. 1992 Dec;54(6):1085–1089. doi: 10.1097/00007890-199212000-00025. [DOI] [PubMed] [Google Scholar]
  16. Ono K., Lindsey E. S. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg. 1969 Feb;57(2):225–229. [PubMed] [Google Scholar]
  17. Peugh W. N., Superina R. A., Wood K. J., Morris P. J. The role of H-2 and non-H-2 antigens and genes in the rejection of murine cardiac allografts. Immunogenetics. 1986;23(1):30–37. doi: 10.1007/BF00376519. [DOI] [PubMed] [Google Scholar]
  18. Qian S. G., Fung J. J., Demetris A. V., Ildstad S. T., Starzl T. E. Orthotopic liver transplantation in the mouse. Transplantation. 1991 Sep;52(3):562–564. doi: 10.1097/00007890-199109000-00039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Qian S., Demetris A. J., Murase N., Rao A. S., Fung J. J., Starzl T. E. Murine liver allograft transplantation: tolerance and donor cell chimerism. Hepatology. 1994 Apr;19(4):916–924. doi: 10.1002/hep.1840190418. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Stepkowski S. M., Raza-Ahmad A., Duncan W. R. The role of class I and class II MHC antigens in the rejection of vascularized heart allografts in mice. Transplantation. 1987 Dec;44(6):753–759. doi: 10.1097/00007890-198712000-00006. [DOI] [PubMed] [Google Scholar]
  21. Stewart R., Butcher G., Herbert J., Roser B. Graft rejection in a congenic panel of rats with defined immune response genes for MHC class I antigens. I. Rejection of and priming to the RT1Aa antigen. Transplantation. 1985 Oct;40(4):427–432. doi: 10.1097/00007890-198510000-00016. [DOI] [PubMed] [Google Scholar]
  22. Stewart R., Stephenson P., Godden U., Butcher G., Roser B. Graft rejection in a congenic panel of rats with defined immune response genes for class I antigens. II. Quantitative aspects of Ir gene function in a full-haplotype mismatch. Transplantation. 1985 Oct;40(4):432–436. doi: 10.1097/00007890-198510000-00017. [DOI] [PubMed] [Google Scholar]
  23. Streilein J. W., Strome P., Wood P. J. Failure of in vitro assays to predict accurately the existence of neonatally induced H-2 tolerance. Transplantation. 1989 Oct;48(4):630–634. [PubMed] [Google Scholar]
  24. Thomas J., Thomas F., Mendez-Picon G., Lee H. Immunological monitoring of long-surviving renal transplant recipients. Surgery. 1977 Feb;81(2):125–131. [PubMed] [Google Scholar]
  25. Zijlstra M., Auchincloss H., Jr, Loring J. M., Chase C. M., Russell P. S., Jaenisch R. Skin graft rejection by beta 2-microglobulin-deficient mice. J Exp Med. 1992 Apr 1;175(4):885–893. doi: 10.1084/jem.175.4.885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Zijlstra M., Bix M., Simister N. E., Loring J. M., Raulet D. H., Jaenisch R. Beta 2-microglobulin deficient mice lack CD4-8+ cytolytic T cells. Nature. 1990 Apr 19;344(6268):742–746. doi: 10.1038/344742a0. [DOI] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES